Merck (MRK) Equity Income (2009 - 2014)

Merck (MRK) has 5 years of Equity Income data on file, last reported at $16.0 million in Q4 2014.

• Equity Income for Q4 2014 came in at $16.0 million, down 69.81% year-over-year; the trailing twelve-month figure through Dec 2014 was $256.0 million (down 36.63% YoY), and the FY2014 annual result was $257.0 million, down 36.39% from the prior year.
• Equity Income declined to $16.0 million in Q4 2014 per MRK's latest filing, from $24.0 million in the prior quarter.
• Over five years, Equity Income peaked at $256.0 million in Q4 2011 and troughed at $16.0 million in Q4 2014.
• A 4-year average of $122.8 million and a median of $120.0 million in 2013 frame the typical range for Equity Income.
• On a YoY basis, Equity Income climbed as much as 20.91% in 2013 and fell as far as 77.16% in 2013.
• A 4-year view of Equity Income shows it stood at $256.0 million in 2011, then decreased by 9.38% to $232.0 million in 2012, then slumped by 77.16% to $53.0 million in 2013, then slumped by 69.81% to $16.0 million in 2014.
• Business Quant data shows MRK's Equity Income at $16.0 million in Q4 2014, $24.0 million in Q3 2014, and $92.0 million in Q2 2014.